GLP-1 Weight Loss at 8 Weeks: Two-Month Results

Quick Answer

At 8 weeks on GLP-1, most patients have lost 6–12 lbs. This is typically the period of fastest weight loss per week, as the dose is stepping up significantly (semaglutide moving toward 1 mg) and appetite suppression is increasing. Side effects often begin to improve meaningfully around weeks 6–8 as the gut adapts.

Where You Are in the Titration at 8 Weeks

By week 8, most GLP-1 titration schedules are well into the dose-building phase:

Semaglutide (Wegovy):

Weeks 1–4: 0.25 mg
Weeks 5–8: 0.5 mg
Week 8 is the final week before moving to 1.0 mg

Tirzepatide (Zepbound):

Weeks 1–4: 2.5 mg
Weeks 5–8: 5 mg
Week 8 is the final week before moving to 7.5 mg

At 0.5 mg semaglutide, you're experiencing roughly 50–60% of the full 2.4 mg appetite-suppressing effect. The next four weeks on 1 mg will produce a noticeable jump in efficacy for most patients.

Typical Weight Loss at 8 Weeks

From the STEP 1 trial week-by-week data and real-world reports:

Average at 8 weeks (semaglutide): approximately 8–10 lbs
Average at 8 weeks (tirzepatide): approximately 10–13 lbs
High responders at 8 weeks: 15–20 lbs possible
Low/typical early responders: 4–6 lbs

The rate of loss typically accelerates between weeks 8–20 as doses increase toward target. Week 8 is not the ceiling — it's often the midpoint of peak rapid-loss phase.

Side Effects at 8 Weeks: Getting Better

One of the most encouraging aspects of the 8-week mark is side effect improvement. The STEP 1 trial data shows:

Nausea peaks around weeks 2–6 and begins declining significantly by weeks 7–12
Most patients describe week 8 as "noticeably better" than weeks 2–4
Constipation, if present, typically becomes more manageable as dietary patterns adjust
Energy levels start to stabilize or improve for most patients

If you're still experiencing significant nausea at week 8, discuss with your provider — slow titration, anti-nausea medication, or dietary adjustments may help.

What 8-Week Results Predict

Research from the STEP trials suggests that response at 12–16 weeks at adequate doses is a reasonable early predictor:

Patients who have lost ≥5% by week 12 at 1 mg (semaglutide) have high probability of eventually reaching the 10–15% response range
Patients losing less than 2% by week 16 at 1.7 mg may be partial responders and warrant dose maximization and lifestyle discussion

Week 8 at 0.5 mg is still early, but a complete absence of any appetite change or any weight movement warrants a conversation with your provider.

Optimizing Results at the 8-Week Mark

Patients who see the best results tend to have made these adjustments by week 8:

Protein focus: Aiming for 100–130g of protein daily helps preserve lean mass as weight loss accelerates.

Smaller, more frequent meals: Rather than fighting the medication's gastric-slowing effect, working with it — eating 4–5 small meals rather than 2–3 large ones — reduces nausea and maintains adequate nutrition.

Movement habit: Adding a 20–30 minute daily walk, if not already present, significantly amplifies the caloric deficit.

Alcohol reduction: Alcohol is calorie-dense, can worsen GI symptoms, and may blunt the medication's effectiveness for some patients.

Ready to Start Your GLP-1 Journey?

Bottom Line

Eight weeks on GLP-1 typically means 8–12 lbs lost, improving side effects, and approaching the first major dose increase. Most patients describe week 8 as the turning point where the medication starts "really working" — the appetite suppression becomes unmistakably clear.